BioWorld

March 5, 2003

View Archived Issues

ILEX Gets Non-Oncology Rights To Campath Leukemia Treatment

In Vivo Adenoviral Gene Transfer Inefficient In Aged Cardiac Muscle In Comparison With Adult Hearts

YM BioSciences Receives FDA Nod For Phase III Cancer Trial

Viragen Continues Restructuring To Sustain Remaining Resources

Aphton Releases Phase III Data, Prepares For Regulatory Filings

Other News To Note

TNF Drugs Not Implicated In Lymphoma Risk, Panel Says

The risk of lymphoma in the rheumatoid arthritis population doesn't appear to increase among patients taking a TNF blocker, members of an FDA advisory panel said on Tuesday. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for June 22, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

Nankai University and Accendatech present new majusculamide D derivatives

BioWorld Science

Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...